QART Medical (read: Q – Art) is addressing the quiet global infertility epidemic. As fertile sperm cells percentage for a normal male is in decline, in-vitro fertilization (IVF) becomes a ubiquitous solution. This process is currently hindered by the transparent nature of sperm cells, making it difficult for an embryologist to select healthy cells for transplant.
QART (Quantitative Assisted Reproductive Technologies) develops a breakthrough solution for highly informative characterization and selection of sperm cells, aiming to create a new and better gold standard in the ART market and improve current success rates of Intra-Cytoplasmic Sperm Injection (ICSI) by:
Quantitatively characterizing the morphology and contents of individual sperm cells with 3D topographic imaging.
Providing quantitative DNA integrity information, on a cell-by-cell basis.
Automatically sorting a semen sample according to objective consensus criteria.
Alon Shalev, MSc
Alon Shalev, QART’s co-founder and CEO, brings his vast business and development experience in the medical devices field.
Alon is an entrepreneur, inventor and executive in the Med-Tech domain. Was co-founder and COO in BrainsGate, CEO in Nicast, co-founder and CEO in Endospan. Received his BSc and MSc (Summa Cum Laude) in Electrical Engineering from the Tel Aviv University.
Prof. Natan T. Shaked, PhD
Chief Scientist, Co-Founder
Natan Shaked - QART’s co-founder and chief scientist, brings his immense research experience and know- how as well as his expertise with holographic imaging of sperm cells.
Natan is an associate Professor in the Department of Biomedical Engineering at Tel Aviv University. Was a Visiting Assistant Professor in the Dept. of Biomedical Engineering at Duke University, Durham, NC, USA. Received his BSc, MSc (Summa Cum Laude), and PhD degrees in Electrical and Computer Engineering.
Dr. Mattan Levi, PhD
Director Translational Research
Mattan Levi, QART’s director of Translational research brings his vast practical medical experience with clinical embryology and IVF research.
Mattan is an experienced clinical embryologist, founder and director of the medical andrology laboratory at Herzliya Medical Center. Received B.Sc. (magna cum laude), M.Sc. (summa cum laude) and Ph.D in Cell and Developmental Biology. Two decades of scientific research at the fields of reproductive and cancer biology included teaching embryology, histology and molecular Imaging at Tel Aviv University, fellowship at Pierre et Marie Curie University, foundation and management of oncology research laboratory at Rabin Medical Center, publication of 30 peer-reviewed scientific articles, chapters in textbooks and invited reviews, received prestigious international awards.
Shimon Oz, MBA
Chief Financial Officer
Shimon Oz, QART’s CFO, brings his extensive financial and business management experience.
Shimon has an M.B.A. in Economics and Business Admin. & master’s degree in economics and Business Administration (with honors) from the Department of Economics, Hebrew University, Jerusalem. Served as an independent adviser acting as executive director and/or CFO, investment banker, and economic consultant for clients including Scitex Corp, Forum Film, Elan Jaglom Group, Mig Group, “Infinity VC Group, Dekora Group and others.
Arik Drori MBA, BSc
Arik Drori, QART’s VP R&D, brings over 20 years’ experience in R&D with well-developed leadership and problem-solving skills.
Arik is an innovator with out-of-the-box nonconventional way of thinking. Led system & development teams in Real-imaging, GE-Versamed, Optical-imaging, and more.
Arik holds a BSc in electrical engineering from Tel-Aviv University, and MBA from Heriot-watt university in Scotland.
Orly Schwart, BSc
VP QA, RA
& Clinical Affairs
VP QA, RA
& Clinical Affairs
over 18 years of operational and executive clinical & regulatory experience in MedTech.
Managed multi-center, multi-continent clinical studies, submission to EU for CE marking, US FDA, PMDA Japan and AMAR Israel.
Orly holds a BSc in Biomedical Engineering from Tel Aviv University.
Oren Lev MBA, BSc
Director of Software Engineering
Oren Lev, QART’s Director of Software Engineering and Architecture, brings years of experience in SW design for medical devices and other fields.
Oren was CTO at FuturingUp, Director of software at Real imaging, and led design and development at BMC and Perion.
Oren holds a BSc. (cum laude) in Aeronautics and Space Engineering, and MBA, both from the Technion.
Dana Goldkorn, QART’s SW and Algorithm engineer brings exceptional programming know-how and experience with holographic imaging.
Dana is finalizing her M. Sc in electrical engineering from Tel-Aviv university, developing image processing algorithms for holographic imaging.
Dr. Susan Alpert, MD, PhD
Dr. Alpert held the positions of senior vice president and chief regulatory officer at Medtronic until 2012 and a similar role at C.R. Bard. Before Medtronic, she held a number of positions with the FDA including as Director of the FDA’s Office of Device Evaluation. Dr. Alpert holds MD and Ph.D. in infectious diseases from the NYC School of Medicine.